U.S. Markets closed

Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
153.89+2.56 (+1.69%)
At close: 04:00PM EDT
154.31 +0.42 (+0.27%)
After hours: 05:27PM EDT

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911

IndustryDiagnostics & Research
Full Time Employees4,700

Key Executives

NameTitlePayExercisedYear Born
Dr. August James Troendle M.D.Chairman & CEO1.54M23.07M1956
Mr. Jesse J. Geiger BBA, CPAPres805.42k2.83M1974
Mr. Kevin M. BradyCFO & Treasurer547.17k169.81k1974
Ms. Susan E. BurwigExec. VP of Operations910.29k2.3M1963
Mr. Stephen P. EwaldChief Compliance Officer, Gen. Counsel & Corp. Sec.753.98k2.61M1969
Brandon EbkenChief Information OfficerN/AN/AN/A
Ms. Lauren MorrisAssociate Director of Investors RelationsN/AN/AN/A
Mr. Todd MeyersVP of Bus. Devel. & MarketingN/AN/AN/A
Mr. Weimin Gai MSSr. VP of BiometricsN/AN/AN/A
Mr. Daniel O'LearySr. VP of Medical DepartmentN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Corporate Governance

Medpace Holdings, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 9. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.